These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11893468)

  • 1. Insulin resistance and metabolic parameters in type 2 diabetic patients.
    Metzler W; Fischer S; Köhler C; Pistrosch F; Kindel B; Hanefeld M
    Eur J Intern Med; 2002 Mar; 13(2):108-114. PubMed ID: 11893468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo?
    Burén J; Lindmark S; Renström F; Eriksson JW
    Metabolism; 2003 Feb; 52(2):239-45. PubMed ID: 12601640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Insulin resistance and insulin secretion in type II non-obese diabetics].
    Pelikánová T; Válek J; Kazdová L; Saudek F; Karasová L
    Cas Lek Cesk; 1994 Mar; 133(6):172-6. PubMed ID: 8156572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects.
    Pratipanawatr T; Pratipanawatr W; Rosen C; Berria R; Bajaj M; Cusi K; Mandarino L; Kashyap S; Belfort R; DeFronzo RA
    Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1360-8. PubMed ID: 12006367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin sensitivity in Type 1 diabetic children and adolescents.
    Szadkowska A; Pietrzak I; Mianowska B; Bodalska-Lipińska J; Keenan HA; Toporowska-Kowalska E; Młynarski W; Bodalski J
    Diabet Med; 2008 Mar; 25(3):282-8. PubMed ID: 18279410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Youth type 2 diabetes: insulin resistance, beta-cell failure, or both?
    Gungor N; Bacha F; Saad R; Janosky J; Arslanian S
    Diabetes Care; 2005 Mar; 28(3):638-44. PubMed ID: 15735201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of hepatic insulin action in obese type 2 diabetic patients.
    Staehr P; Hother-Nielsen O; Levin K; Holst JJ; Beck-Nielsen H
    Diabetes; 2001 Jun; 50(6):1363-70. PubMed ID: 11375337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.
    Nam SY; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
    Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1101-7. PubMed ID: 11477493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance in the first-degree relatives of persons with type 2 diabetes.
    Straczkowski M; Kowalska I; Stepień A; Dzienis-Straczkowska S; Szelachowska M; Kinalska I; Krukowska A; Konicka M
    Med Sci Monit; 2003 May; 9(5):CR186-90. PubMed ID: 12761455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Power spectral analysis of heart rate variability during hyperinsulinemia in nondiabetic offspring of type 2 diabetic patients: evidence for possible early autonomic dysfunction in insulin-resistant subjects.
    Laitinen T; Vauhkonen IK; Niskanen LK; Hartikainen JE; Länsimies EA; Uusitupa MI; Laakso M
    Diabetes; 1999 Jun; 48(6):1295-9. PubMed ID: 10342819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects.
    Jacob S; Machann J; Rett K; Brechtel K; Volk A; Renn W; Maerker E; Matthaei S; Schick F; Claussen CD; Häring HU
    Diabetes; 1999 May; 48(5):1113-9. PubMed ID: 10331418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using the hyperinsulinemic euglycemic clamp to assess insulin sensitivity at 3 months following Roux-en-Y gastric bypass surgery in type 2 diabetes patients with BMI <35 kg/m
    Zhao L; Zhu L; Su Z; Liu Y; Li P; Yang X; Li W; Tan L; Sun X; Zhu S
    Int J Surg; 2017 Feb; 38():90-94. PubMed ID: 28043929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation, insulin resistance, and adiposity: a study of first-degree relatives of type 2 diabetic subjects.
    Kriketos AD; Greenfield JR; Peake PW; Furler SM; Denyer GS; Charlesworth JA; Campbell LV
    Diabetes Care; 2004 Aug; 27(8):2033-40. PubMed ID: 15277436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance in type 2 diabetes: association with truncal obesity, impaired fitness, and atypical malonyl coenzyme A regulation.
    Båvenholm PN; Kuhl J; Pigon J; Saha AK; Ruderman NB; Efendic S
    J Clin Endocrinol Metab; 2003 Jan; 88(1):82-7. PubMed ID: 12519834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular partition of plasma glucose disposal in hypertensive and normotensive subjects with type 2 diabetes mellitus.
    Bonora E; Targher G; Alberiche M; Bonadonna RC; Zenere MB; Saggiani F; Muggeo M
    J Clin Endocrinol Metab; 2001 May; 86(5):2073-9. PubMed ID: 11344209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects.
    Anderwald C; Anderwald-Stadler M; Promintzer M; Prager G; Mandl M; Nowotny P; Bischof MG; Wolzt M; Ludvik B; Kästenbauer T; Pacini G; Luger A; Krebs M
    Diabetes Care; 2007 Sep; 30(9):2374-80. PubMed ID: 17595351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
    Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
    Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance.
    Del Prato S; Nosadini R; Tiengo A; Tessari P; Avogaro A; Trevisan R; Valerio A; Muggeo M; Cobelli C; Toffolo G
    J Clin Endocrinol Metab; 1983 Nov; 57(5):904-10. PubMed ID: 6352727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance is associated with impaired nitric oxide synthase activity in skeletal muscle of type 2 diabetic subjects.
    Kashyap SR; Roman LJ; Lamont J; Masters BS; Bajaj M; Suraamornkul S; Belfort R; Berria R; Kellogg DL; Liu Y; DeFronzo RA
    J Clin Endocrinol Metab; 2005 Feb; 90(2):1100-5. PubMed ID: 15562034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro.
    Yki-Järvinen H; Taskinen MR; Kiviluoto T; Hilden H; Helve E; Koivisto VA; Nikkilä EA
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1183-92. PubMed ID: 6490795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.